Price Alert

Sabra Health Care REIT In... (SBRA)

NASDAQ: SBRA · Real-Time Price · USD

18.45

0.00 (0.03%)

At close: Aug 15, 2025, 3:59 PM

18.63

1.00%

After-hours: Aug 15, 2025, 05:59 PM EDT

Sabra Health Care REIT Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	189.15M	183.54M	182.35M	178M	178.53M	172.2M	164.38M	161.63M	161.17M	161.32M	164.99M	140.76M	155.96M	163.1M	135.66M	128.59M	152.93M	152.37M
Cost of Revenue	61.1M	59.93M	59.84M	48.49M	96.43M	96.91M	92.75M	48.83M	48.73M	47.8M	43.8M	41.83M	38.88M	38.12M	37.38M	35.84M	33.9M	34.08M
Gross Profit	128.05M	123.61M	122.51M	129.51M	82.1M	75.29M	71.63M	112.8M	112.43M	113.52M	121.19M	98.94M	117.08M	124.99M	98.27M	92.75M	119.03M	118.28M
Operating Income	71.95M	67.39M	67.29M	64.52M	69.62M	60.64M	69.94M	148.85M	57.67M	49.9M	-28.06M	37.67M	58.84M	66.13M	1.85M	39.05M	65.84M	62.95M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	15.6M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	66.04M	40.5M	47.08M	29.52M	24.41M	26.71M	17.65M	-14.65M	21.51M	-8.76M	-84.82M	-49.48M	17.06M	40.89M	-23.82M	10.31M	-132.05M	34.15M
Net Income	65.54M	40.3M	46.7M	29.79M	23.98M	26.25M	17.16M	-15.1M	21.19M	-9.49M	-84.95M	-50.06M	16.8M	40.6M	-24.35M	10.22M	-132.57M	33.45M
Selling & General & Admin	12.51M	12.73M	13.03M	12.4M	12.74M	11.89M	16.68M	10.76M	9.53M	10.5M	10.85M	9.68M	8.65M	10.4M	8.24M	8.68M	8.81M	8.94M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	43.59M	n/a	42.18M	n/a	78K	-14.65M	-1.69M	2.23M	-9.96M	52.62M	50.08M	994K	44.9M	45.73M	-13K	277K	-24K	133K
Operating Expenses	56.1M	12.73M	55.22M	12.4M	54.26M	14.65M	1.69M	54.33M	54.1M	63.12M	60.93M	56.89M	53.55M	56.13M	55.36M	53.7M	53.19M	55.34M
Interest Expense	27.55M	n/a	28.08M	29.47M	29.31M	28.41M	43.54M	28.16M	28.33M	28.54M	27.9M	27.07M	25.53M	24.97M	25.68M	24.24M	24.27M	24.44M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-20.07M	n/a	n/a	n/a	-26.43M	n/a	n/a	n/a
Cost & Expenses	117.2M	12.73M	115.05M	60.89M	108.91M	111.56M	94.44M	103.16M	102.84M	110.93M	104.73M	98.71M	92.43M	94.24M	92.75M	89.54M	87.09M	89.42M
Income Tax Expense	497K	-413K	380K	-265K	437K	453K	493K	455K	326K	728K	124K	579K	255K	284K	531K	92K	522K	700K
Shares Outstanding (Basic)	237.98M	237.89M	236.6M	234.29M	231.62M	231.45M	231.22M	231.22M	231.2M	231.16M	230.99M	230.98M	230.97M	230.86M	219.31M	220.87M	214.42M	211.45M
Shares Outstanding (Diluted)	240.93M	240.3M	239.64M	237.04M	233.75M	233.37M	233.2M	231.22M	232.24M	231.16M	230.99M	230.98M	231.68M	231.56M	227.52M	222.06M	216.26M	212.62M
EPS (Basic)	0.28	0.17	0.20	0.13	0.10	0.11	0.07	-0.07	0.09	-0.04	-0.37	-0.22	0.07	0.18	-0.11	0.05	-0.62	0.16
EPS (Diluted)	0.27	0.17	0.19	0.13	0.10	0.11	0.07	-0.07	0.09	-0.04	-0.37	-0.22	0.07	0.18	-0.11	0.05	-0.61	0.16
EBITDA	137.17M	111.31M	125.19M	101.71M	108.81M	100.41M	112.82M	101.07M	101.82M	102.73M	-36.11M	-3.22M	104.01M	111.39M	46.93M	244.18M	-59.46M	102.31M
EBIT	93.59M	67.82M	82.89M	58.99M	53.73M	55.12M	45.59M	13.51M	49.84M	19.78M	-56.93M	41.45M	42.59M	65.86M	1.85M	34.56M	-107.78M	58.59M
Depreciation & Amortization	43.59M	43.49M	42.31M	42.72M	41.68M	42.91M	42.88M	43.24M	44.14M	52.83M	49.93M	47.43M	45.17M	45.26M	45.08M	45.05M	44.49M	44.38M